Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Catalyst Pharmaceuticals Inc (CPRX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Catalyst Pharmaceuticals's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
15.100 -0.030    -0.20%
22/04 - Closed. Currency in USD ( Disclaimer )
Pre Market
15.050
-0.050
-0.331%
6:48:25 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 1,015,042
  • Bid/Ask: 15.100 / 15.750
  • Day's Range: 14.930 - 15.350
Catalyst Pharmaceuticals 15.100 -0.030 -0.20%

CPRX Recent Sentiments

 
This page contains information on users’ sentiments for the Catalyst Pharmaceuticals Inc stock, which are displayed both on charts of different periods of time and on a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
Apr 18, 2024 Mohammed Rahman   15.750 Apr 22, 2024 @ 15.020 -4.63%
Apr 12, 2024 Fabian Deheza Clavijo   15.710 Apr 15, 2024 @ 15.730 +0.13%
Apr 03, 2024 Mark Pycroft   15.300 -1.31%
Mar 28, 2024 Matteo Dolfi   16.250 Apr 19, 2024 @ 15.130 -6.89%
Mar 27, 2024 Issam Ben Ayed   16.605 Apr 19, 2024 @ 15.130 -8.88%
Mar 15, 2024 Bill Rader   16.180 Apr 05, 2024 @ 15.170 -6.24%
Mar 01, 2024 준혁 이   17.065 Mar 01, 2024 @ 17.065 0.00%
Feb 29, 2024 Mark Pycroft   15.940 Mar 22, 2024 @ 15.730 -1.32%
Feb 28, 2024 Zoltan Szorad   14.500 Mar 22, 2024 @ 15.730 +8.48%
Feb 28, 2024 Miguel Ángel Angulo...   14.480 Mar 22, 2024 @ 15.730 +8.63%
Feb 23, 2024 Victor Justo   14.080 Mar 15, 2024 @ 16.070 +14.13%
Feb 22, 2024 Stelove   13.820 Mar 15, 2024 @ 16.070 +16.28%
Feb 12, 2024 Claudio Masoli   13.710 Feb 19, 2024 @ 14.000 +2.12%
Feb 08, 2024 Khun Biw   13.205 Mar 01, 2024 @ 17.010 +28.81%
Feb 05, 2024 Mark Pycroft   13.360 Feb 29, 2024 @ 16.090 +20.43%
Jan 23, 2024 Miguel Ángel Angulo...   14.865 Feb 16, 2024 @ 14.000 -5.82%
Jan 11, 2024 Ishtiaq Bokhari   14.730 Feb 02, 2024 @ 13.620 -7.54%
Jan 05, 2024 kermit dekikker   14.690 Jan 26, 2024 @ 14.290 +2.72%
Jan 05, 2024 Victor Justo   14.675 Jan 26, 2024 @ 14.290 -2.62%
Dec 19, 2023 Mario Neira   14.360 Dec 25, 2023 @ 16.580 +15.46%
Dec 01, 2023 Victor Justo   14.750 Dec 22, 2023 @ 16.580 +12.41%
Nov 09, 2023 Tommy XXX   12.680 Nov 30, 2023 @ 14.050 +10.80%
Nov 07, 2023 Pierre hiard   12.975 Dec 01, 2023 @ 14.820 +14.22%
Nov 03, 2023 Gerardo Mendez   12.935 Nov 30, 2023 @ 14.050 +8.62%
Nov 01, 2023 Jose Novais   12.000 Nov 30, 2023 @ 14.050 +17.08%
Oct 28, 2023 Giacomo Mion   12.000 Nov 30, 2023 @ 14.050 -17.08%
Oct 27, 2023 Stephen Jones   12.005 Nov 30, 2023 @ 14.050 +17.03%
Oct 17, 2023 Ivan Ruiz   13.249 Nov 30, 2023 @ 14.050 +6.05%
Sep 29, 2023 Japjot Pal Singh...   12.260 Nov 30, 2023 @ 14.050 +14.60%
Sep 18, 2023 James King   12.655 Nov 30, 2023 @ 14.050 +11.02%
Sep 18, 2023 Federico Palotero   12.590 Nov 30, 2023 @ 14.050 +11.60%
Sep 05, 2023 Ivan Drobyshevsky   12.975 Sep 05, 2023 @ 12.975 0.00%
Sep 05, 2023 Андрей Кабраль   13.020 Nov 30, 2023 @ 14.050 +7.91%
Aug 11, 2023 Victor Justo   15.280 Nov 30, 2023 @ 14.050 -8.05%
Aug 10, 2023 Lai   15.149 Nov 30, 2023 @ 14.050 -7.25%
Aug 10, 2023 YEOHCL   14.875 Nov 30, 2023 @ 14.050 -5.55%
Jul 26, 2023 María Álvarez   13.320 Nov 30, 2023 @ 14.050 +5.48%
Jul 18, 2023 MEHMET ALİ GÜNDOĞDU   13.790 Jul 30, 2023 @ 13.970 +1.31%
Jun 29, 2023 עמוס קוק   13.520 Nov 30, 2023 @ 14.050 +3.92%
Jun 21, 2023 Jesús alonso   12.905 Nov 30, 2023 @ 14.050 +8.87%
Jun 14, 2023 Solih Sulaymon   11.495 Nov 30, 2023 @ 14.050 +22.23%
Jun 12, 2023 Luca Gianoli   12.015 Nov 30, 2023 @ 14.050 +16.94%
May 30, 2023 Andrea Masciadri   11.500 Nov 30, 2023 @ 14.050 +22.17%
May 30, 2023 Ernesto Medina   11.385 Nov 30, 2023 @ 14.050 -23.41%
May 18, 2023 Eleonora Venti   12.100 Nov 30, 2023 @ 14.050 +16.12%
May 17, 2023 Radek Bielinski   12.335 Nov 30, 2023 @ 14.050 +13.90%
May 12, 2023 Wyman Tan   13.700 Nov 30, 2023 @ 14.050 +2.55%
May 11, 2023 Mark Pycroft   14.550 Jun 30, 2023 @ 13.710 -5.77%
May 03, 2023 Pablo Criado Pernía   16.590 Nov 30, 2023 @ 14.050 -15.31%
May 03, 2023 泰隆 太田垣   16.519 Nov 30, 2023 @ 14.050 -14.95%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CPRX Comments

Write your thoughts about Catalyst Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Ishtiaq Bokhari
Ishtiaq Bokhari Jan 11, 2024 10:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
the recent Morgan Stanley convention for the pharmaceutical in San Francisco CPR access proving to be liquidate company and is very well performing and it's way up and a good time to jump on the boat
Giuseppe Giannachi
Giuseppe Giannachi Jan 23, 2023 10:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Wow... what happened? Any news?
Timothy Murphy
Timothy Murphy Sep 24, 2022 4:57PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
we need a rally boys!
jatin par
jatin par Sep 15, 2022 1:53PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why down today?
Timothy Murphy
Timothy Murphy Aug 13, 2022 4:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
great investment, lets hope for even better profits, ahead!
Feb 02, 2021 11:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This is the ultimate bull case no reckless gambling.. The best stock
Feb 02, 2021 11:58AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The best stock with unlimited upside and practically no downside.
Feb 01, 2021 11:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Best Stock in industry healthy robust balance sheet plenty of cash and highly profitable! soo cheap
Imtanis Farah
Imtanis Farah Jan 07, 2021 12:26PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://ir.catalystpharma.com/news-releases/news-release-details/catalyst-pharmaceuticals-announces-strategic-plan-product
Santosh Gujar
Santosh Gujar Dec 22, 2020 12:07PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
next target 5.01
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email